Nontuberculous Mycobacteria
- 1 July 1999
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 160 (1) , 15-21
- https://doi.org/10.1164/ajrccm.160.1.9812080
Abstract
A gold mining work force was followed prospectively over 1 yr for sputum nontuberculous mycobacterial (NTM) isolates. NTM were isolated from 118 men, of whom 32 (27%) met the American Thoracic Society (ATS) case-definitions for pulmonary NTM disease (23 M. kansasii, seven M. scrofulaceum, one M. avium, and one M. abscessus). Determining isolate significance was difficult because most men had been started on presumptive TB treatment before isolate identification (70%). Histologic criteria were considered inappropriate for this high M. tuberculosis incidence population, particularly for patients who had stabilized on presumptive TB treatment. Among men not meeting case-definitions, indicators of disease were significantly more prevalent for M. kansasii than for M. fortuitum, the local laboratory contaminant (ORs: 6.5 for cough, 7.2 for smear-positivity, 36.0 for radiologic changes, and 14.3 for presumptive TB treatment), suggesting underdiagnosis of M. kansasii disease. Of 53 men with definite or possible M. kansasii disease, 18 (34%) were HIV-positive. HIV-associated M. kansasii disease occurred at an early stage of immunosuppression (median CD4 count, 381 × 106/L) with a good outcome (83% cured after 12 mo of treatment). ATS case-definitions for NTM disease are difficult to apply in this population, and treatment decisions should be guided by the pathogenic potential of the isolate.Keywords
This publication has 17 references indexed in Scilit:
- The Impact of HIV Infection on Mycobacterium kansasii Disease in South African Gold MinersAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Risk Factors for Pulmonary Mycobacterial Disease in South African Gold MinersAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Mycobacterium kansasiiDisease in Patients Infected with Human Immunodeficiency VirusClinical Infectious Diseases, 1997
- Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis.Thorax, 1996
- Radiologic manifestations of pulmonary tuberculosis in HIV-1- and HIV-2-infected patients in Abidjan, Côte d'IvoireTubercle and Lung Disease, 1995
- Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Research Committee, British Thoracic Society.Thorax, 1994
- Mycobacterium kansasii Among Patients Infected with Human Immunodeficiency Virus in Kansas CityClinical Infectious Diseases, 1994
- Mycobacterium kansasii Infections in Patients Positive for Human Immunodeficiency VirusClinical Infectious Diseases, 1991
- Mycobacterium kansasii: A Cause of Treatable Pulmonary Disease Associated with Advanced Human Immunodeficiency Virus (HIV) InfectionAnnals of Internal Medicine, 1991
- Pulmonary and Disseminated Infection Due to Mycobactirium kansasii: A Decade of ExperienceClinical Infectious Diseases, 1990